SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Edelman Joseph, et al. – ‘4’ for 2/20/24 re: Cerevel Therapeutics Holdings, Inc.

On:  Wednesday, 2/21/24, at 4:54pm ET   ·   For:  2/20/24   ·   As:  Director   ·   Accession #:  1062993-24-3957   ·   File #:  1-39311

Previous ‘4’:  ‘4’ on 2/20/24 for 2/15/24   ·   Next:  ‘4’ on 4/3/24 for 4/1/24   ·   Latest:  ‘4’ on 4/15/24 for 4/11/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/21/24  Edelman Joseph                    4          Director    1:8K   Cerevel Theraps Holdings, Inc.    Newsfile Corp./FA
          Perceptive Advisors LLC
          Perceptive Life Sciences Master Fund Ltd.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      8K 
                Securities by an Insider -- form4.xml/5.8                        




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  2/20/24
Issuer:
Issuer CIK:  1805387
Issuer Name:  Cerevel Therapeutics Holdings, Inc.
Issuer Trading Symbol:  CERE
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1224962
Owner Name:  PERCEPTIVE ADVISORS LLC
Reporting Owner Address:
Owner Street 1:  51 ASTOR PLACE, 10TH FLOOR
Owner Street 2:
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10003
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1249675
Owner Name:  PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Reporting Owner Address:
Owner Street 1:  51 ASTOR PLACE, 10TH FLOOR
Owner Street 2:
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10003
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1164426
Owner Name:  EDELMAN JOSEPH
Reporting Owner Address:
Owner Street 1:  51 ASTOR PLACE, 10TH FLOOR
Owner Street 2:
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10003
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Aff 10b5 One:  0
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  2/20/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  G
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  170,317
Transaction Price Per Share:
Value:  0.00
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F1
Non-Derivative Holding:
Security Title:
Value:  Common Stock
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  10,794,876
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F2
Footnotes:
Footnote - F1Prior to the disposition reported on this Form 4, the securities were directly held by C2 Life Sciences, LLC ("C2"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of C2, and Mr. Edelman is the managing member of the Advisor.
Footnote - F2The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). The Advisor serves as the investment manager of Master Fund. Mr. Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Owner Signature:
Signature Name:  /s/ Joseph Edelman for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, by Joseph Edelman, its managing member
Signature Date:  2/21/24
Owner Signature:
Signature Name:  /s/ Joseph Edelman for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Signature Date:  2/21/24
Owner Signature:
Signature Name:  /s/ Joseph Edelman
Signature Date:  2/21/24


Top
Filing Submission 0001062993-24-003957   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 12:55:27.2am ET